Anthony M Magliocco
Overview
Explore the profile of Anthony M Magliocco including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
96
Citations
2976
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brockton N, Cook L, Magliocco A, Shemanko C, Vogel H, Khan M, et al.
Int J Environ Res Public Health
. 2025 Feb;
22(2).
PMID: 40003468
Women diagnosed with early-stage breast cancer can develop metastatic disease following successful initial treatment, with bone being the most common site of metastases. The Breast to Bone (B2B) cohort study...
2.
Rathbun L, Magliocco A, Bamezai A
Oncotarget
. 2023 May;
14:426-437.
PMID: 37141412
The human Lymphocyte antigen-6 () gene family has recently gained interest for its possible role in tumor progression. We have carried out analyses of all known gene expression and amplification...
3.
Magliocco A, Moughan J, Miyamoto D, Simko J, Shipley W, Gray P, et al.
JAMA Netw Open
. 2022 Nov;
5(11):e2242378.
PMID: 36383379
Importance: Bladder-preserving trimodality therapy can be an effective alternative to radical cystectomy for treatment of muscle-invasive bladder cancer (MIBC), but biomarkers are needed to guide optimal patient selection. The DNA...
4.
Fujii S, Magliocco A, Kim J, Okamoto W, Kim J, Sawada K, et al.
JCO Precis Oncol
. 2022 Jan;
4:6-19.
PMID: 35050726
Purpose: amplification (human epidermal growth factor receptor 2 positivity [HER2]) in metastatic colorectal cancer (mCRC) has important therapeutic implications that necessitate the need for accurate diagnostics. The study purpose was...
5.
Saeed-Vafa D, Marchion D, McCarthy S, Hakam A, Lopez A, Wenham R, et al.
PLoS One
. 2021 Nov;
16(11):e0256615.
PMID: 34813586
Loss of stromal caveolin-1 (Cav-1) is a biomarker of a cancer-associated fibroblast (CAF) phenotype and is related to progression, metastasis, and poor outcomes in several cancers. The objective of this...
6.
Temkin S, Smeltzer M, Dawkins M, Boehmer L, Senter L, Black D, et al.
Cancer
. 2021 Nov;
128(4):654-664.
PMID: 34787913
The high lethality of ovarian cancer in the United States and associated complexities of the patient journey across the cancer care continuum warrant an assessment of current practices and barriers...
7.
Boyle T, Mondal A, Saeed-Vafa D, Ananth S, Ahluwalia P, Kothapalli R, et al.
Front Genet
. 2021 Jun;
12:503830.
PMID: 34093633
We describe the clinical validation of a targeted DNA and RNA-based next-generation sequencing (NGS) assay at two clinical molecular diagnostic laboratories. This assay employs simultaneous DNA and RNA analysis of...
8.
Kopetz S, Guthrie K, Morris V, Lenz H, Magliocco A, Maru D, et al.
J Clin Oncol
. 2020 Dec;
39(4):285-294.
PMID: 33356422
Purpose: mutations are rarely associated with objective responses to the BRAF inhibitor vemurafenib in patients with metastatic colorectal cancer (CRC). Blockade of by vemurafenib causes feedback upregulation of EGFR, whose...
9.
Napoli M, Li X, Ackerman H, Deshpande A, Barannikov I, Pisegna M, et al.
Nat Commun
. 2020 Oct;
11(1):5156.
PMID: 33056990
The most frequent genetic alterations across multiple human cancers are mutations in TP53 and the activation of the PI3K/AKT pathway, two events crucial for cancer progression. Mutations in TP53 lead...
10.
Kho P, Amant F, Annibali D, Ashton K, Attia J, Auer P, et al.
Int J Cancer
. 2020 Aug;
148(2):307-319.
PMID: 32851660
Blood lipids have been associated with the development of a range of cancers, including breast, lung and colorectal cancer. For endometrial cancer, observational studies have reported inconsistent associations between blood...